Tudor Investment Corp’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-79,648
Closed -$584K 2042
2025
Q1
$584K Buy
+79,648
New +$584K ﹤0.01% 1183
2024
Q2
Sell
-74,531
Closed -$678K 1832
2024
Q1
$678K Sell
74,531
-64,200
-46% -$584K ﹤0.01% 1016
2023
Q4
$619K Sell
138,731
-35,436
-20% -$158K 0.01% 1076
2023
Q3
$547K Sell
174,167
-26,676
-13% -$83.8K 0.01% 1096
2023
Q2
$1.04M Buy
200,843
+132,459
+194% +$683K 0.01% 894
2023
Q1
$360K Sell
68,384
-30,954
-31% -$163K 0.01% 1225
2022
Q4
$279K Buy
99,338
+37,563
+61% +$105K 0.01% 1278
2022
Q3
$256K Buy
61,775
+10,736
+21% +$44.5K 0.01% 1343
2022
Q2
$205K Buy
+51,039
New +$205K 0.01% 1368
2022
Q1
Sell
-40,987
Closed -$286K 1839
2021
Q4
$286K Sell
40,987
-53,725
-57% -$375K ﹤0.01% 1349
2021
Q3
$947K Buy
+94,712
New +$947K 0.02% 887
2016
Q1
Sell
-12,700
Closed -$119K 1652
2015
Q4
$119K Buy
+12,700
New +$119K ﹤0.01% 1362
2015
Q3
Sell
-17,663
Closed -$371K 1616
2015
Q2
$371K Buy
+17,663
New +$371K 0.01% 937